ORTHO CLINICAL DIAGNOSTICS H (OCDX) Stock Income Statement
USA - NASDAQ:OCDX - GB00BMDNH979 - Common Stock
17.63
+0.08 (+0.46%)
| TTM (2022-4-3) | 2021 (2022-1-2) | 2020 (2021-1-3) | 2019 (2019-12-29) | 2018 (2018-12-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.04B | 2.04B | 1.77B | 1.80B | 1.79B | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 1.01B | 1.01B | 907.50M | 910.70M | 898.00M | |||
| Gross Profit | 1.03B | 1.04B | 858.70M | 890.80M | 889.30M | |||
| Operating Expenses | 864.50M | 855.10M | 770.30M | 793.40M | 768.20M | |||
| Research and Development | 129.60M | 126.20M | 112.90M | 98.00M | 98.70M | |||
| Selling, General, and Administrative Expenses | 553.10M | 555.00M | 489.60M | 515.10M | 491.60M | |||
| Operating Income | 163.50M | 180.90M | 88.40M | 97.40M | 121.10M | |||
| Interest Income/Expense | -137.40M | -148.30M | -266.40M | -236.90M | -291.30M | |||
| Other Income/Expense | 52.30M | -1.30M | -34.60M | -29.40M | 9.30M | |||
| Non Recurring Items | -50.30M | -57.30M | -12.70M | -11.90M | -56.70M | |||
| Income Before Taxes | 28.10M | -26.00M | -225.30M | -180.80M | -217.60M | |||
| Income Tax | 28.50M | 28.30M | -13.40M | -23.90M | 31.20M | |||
| Net Income | -400.00K | -54.30M | -211.90M | -156.90M | -248.80M | |||
| EBITDA | 488.30M | 509.00M | 414.30M | 424.90M | 453.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.00539358238858649 | -0.23794916739702016 | -0.9519317160826595 | -0.7048517520215634 | -1.1176999101527405 | |||
| Non GAAP EPS | null | 0.81 | null | null | null | |||
| Statistics | ||||||||
| Gross Profit Margin | 50.49% | 50.71% | 48.62% | 49.45% | 49.76% | |||
| Profit Margin | -0.02% | -2.66% | -12.00% | -8.71% | -13.92% | |||
| Operating Profit Margin | 8.03% | 8.86% | 5.01% | 5.41% | 6.78% | |||
All data in USD